Live
Home·Deals·Pharmaceutical·The White House acquires Regeneron
The White House acquires Regeneron (2026)
SEO URLwww.firestrike.ai/deals/regeneron-the-white-house-acquisition-2026
acquisitionAnnounced · Apr 23, 2026PharmaceuticalSource · Unverified ReportsArticle · Factual
Regeneron
The White House
Regeneron · The White House

The White House acquires Regeneron

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$10B
Target
Regeneron
Regeneron
NASDAQ: REGN · Tarrytown, New York
Acquirer
The White House
The White House
Full Acquisition
Status
Announced

The White House agreed to acquire Regeneron. Reported deal value: $10B. Status: Announced. Sector: Pharmaceutical. Target headquarters context: Tarrytown, New York, United States.

This page summarizes publicly available information about the transaction as of 2026-04-23. Figures and status may change as filings and press coverage update.

Copy Link copied The White House is poised to announce a drug pricing deal Thursday with Regeneron

Deal timeline

Announced
Apr 23, 2026 · notus.org
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Pharmaceutical with a reported deal value of $10B. Figures and status may change as sources update.

Sources: notus.org · Primary article · FireStrike proprietary index